Daxor Corporation Stock Analysis & AI Score
Daxor Corporation (DXR) has an ST Score of 63.1 (B), driven by its Forecast (A) and held back by its Momentum (C+). Analysts rate it Buy with a $23.00 price target (+101.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Daxor Corporation (DXR) has an ST Score of 63.1 (B), driven by its Forecast (A) and held back by its Momentum (C+). Analysts rate it Buy with a $23.00 price target (+101.9% upside).
- Strongest
- ForecastA
- Weakest
- MomentumC+
All factor grades
- ForecastA
- ProfitabilityA-
- GrowthB+
- ValuationB-
- Financial StrengthB-
- MomentumC+
- Piotroski4/9
Contact
DXR stock: frequently asked questions
What is DXR's ST Score?
Daxor Corporation (DXR) has an ST Score of 63.1 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is DXR a buy, hold, or sell?
Analysts rate DXR a Buy, with a price target of $23.00 (+101.9% vs the current price). Our ST Score grades it B (63.1/100). The ST Score is a data-driven signal, not a recommendation.
What are DXR's factor grades?
Valuation B-, Profitability A-, Financial Strength B-, Momentum C+, Growth B+, Forecast A.
What is DXR's valuation grade?
Daxor Corporation (DXR) earns a valuation grade of B-, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is DXR's growth grade?
Daxor Corporation (DXR) earns a growth grade of B+, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is DXR's profitability grade?
Daxor Corporation (DXR) earns a profitability grade of A-, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is DXR's financial strength grade?
Daxor Corporation (DXR) earns a financial strength grade of B-, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for DXR?
The average analyst price target for Daxor Corporation (DXR) is $23.00 from 3 analysts, which is +101.9% versus the recent price of $11.39.
What is DXR's Piotroski score?
Daxor Corporation (DXR) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.